Sedation Assessed Using: Treatment-Emergent Adverse Events
"Somnolence" was the only reported sedation-related adverse event
- No reports of "CNS depression," "stupor," or "coma"
Somnolence was reported in 5.1% (28 / 552) ofIM olanzapine-treated patients
No significant difference between IM olanzapine and any other treatment group (including placebo) in the incidence of somnolence.